优化前列腺癌检测的空间穿刺取样策略
本研究基于971例接受MRI-超声融合靶向穿刺的可疑前列腺癌患者,回顾性评估区域靶向穿刺(RTB),仅取影像定义感兴趣区边缘2 cm内的针芯。结果显示RTB与联合穿刺对临床显著前列腺癌(csPCa)检出率相似(44.0% vs 44.8%,p=0.71),但平均每例少取3.8(22%)条针芯;前列腺切除术后升级率无显著差异(p=0.84)。
要点
- RTB与联合穿刺的csPCa检出率相似(44.0% vs 44.8%,p=0.71)。
- RTB平均每例比联合穿刺少取3.8(22%)条针芯。
- RTB与联合穿刺在前列腺切除术后升级率无显著差异(p=0.84)。
核心结论
- 区域靶向穿刺(RTB)可在减少取芯数量的同时维持与联合穿刺相当的csPCa检出率。
研究设计与样本
- 回顾性队列研究,纳入971例接受MRI-超声融合靶向穿刺的可疑前列腺癌患者,共16,459条针芯。
- RTB仅纳入影像定义的感兴趣区边缘2 cm内的针芯。
主要发现
- 在971例患者中,1,535条(9%)针芯含csPCa。
- 系统穿刺、MRI靶向穿刺、联合穿刺和RTB的csPCa检出率分别为27.0%(262/971)、38.3%(372/971)、44.8%(435/971)和44.0%(427/971)。
- 联合穿刺的csPCa检出率显著高于系统穿刺(p <0.001)和MRI靶向穿刺(p=0.004),但与RTB相似(p=0.71)。
- RTB平均每例比联合穿刺少取3.8(22%)条针芯。
- 在102例接受前列腺切除术的患者中,RTB与联合穿刺的升级率无显著差异(p=0.84)。
临床怎么用
- RTB策略可减少前列腺穿刺取芯数量,同时维持csPCa检出率,有助于决策穿刺部位选择和总取芯数。
局限性
- RTB为回顾性评估。
- 前列腺切除术后升级率分析仅基于102例患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The appropriate number of systematic biopsy cores to retrieve during magnetic resonance imaging (MRI)-targeted prostate biopsy is not well defined. We aimed to demonstrate a biopsy sampling approach that reduces required core count while maintaining diagnostic performance. MATERIALS AND METHODS: We collected data from a cohort of 971 men who underwent MRI-ultrasound fusion targeted biopsy for suspected prostate cancer. A regional targeted biopsy (RTB) was evaluated retrospectively; only cores within 2 cm of the margin of a radiologist-defined region of interest were considered part of the RTB. We compared detection rates for clinically significant prostate cancer (csPCa) and cancer upgrading rate on final whole mount pathology after prostatectomy between RTB, combined, MRI-targeted, and systematic biopsy. RESULTS: A total of 16,459 total cores from 971 men were included in the study data sets, of which 1,535 (9%) contained csPCa. The csPCa detection rates for systematic, MRI-targeted, combined, and RTB were 27.0% (262/971), 38.3% (372/971), 44.8% (435/971), and 44.0% (427/971), respectively. Combined biopsy detected significantly more csPCa than systematic and MRI-targeted biopsy (p <0.001 and p=0.004, respectively) but was similar to RTB (p=0.71), which used on average 3.8 (22%) fewer cores per patient. In 102 patients who underwent prostatectomy, there was no significant difference in upgrading rates between RTB and combined biopsy (p=0.84). CONCLUSIONS: A RTB approach can maintain state-of-the-art detection rates while requiring fewer retrieved cores. This result informs decision making about biopsy site selection and total retrieved core count.
引用
- Raman AG, Sarma KV, Raman SS, et al. Optimizing Spatial Biopsy Sampling for the Detection of Prostate Cancer. J Urol. 2021. PMID: 33908801. doi:10.1097/JU.0000000000001832
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。